Pembrolizumab in Small-Cell Lung Cancer: In Search of the Best Biomarker

Egbert F Smit, John B A G Haanen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)3794-3795
Number of pages2
JournalJournal of Clinical Oncology
Volume35
Issue number34
DOIs
Publication statusPublished - 1 Dec 2017

Cite this

@article{3ecd2aa51d4d4a329f61623a83d99dc3,
title = "Pembrolizumab in Small-Cell Lung Cancer: In Search of the Best Biomarker",
author = "Smit, {Egbert F} and Haanen, {John B A G}",
year = "2017",
month = "12",
day = "1",
doi = "10.1200/JCO.2017.74.5141",
language = "English",
volume = "35",
pages = "3794--3795",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "34",

}

Pembrolizumab in Small-Cell Lung Cancer : In Search of the Best Biomarker. / Smit, Egbert F; Haanen, John B A G.

In: Journal of Clinical Oncology, Vol. 35, No. 34, 01.12.2017, p. 3794-3795.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Pembrolizumab in Small-Cell Lung Cancer

T2 - In Search of the Best Biomarker

AU - Smit, Egbert F

AU - Haanen, John B A G

PY - 2017/12/1

Y1 - 2017/12/1

U2 - 10.1200/JCO.2017.74.5141

DO - 10.1200/JCO.2017.74.5141

M3 - Article

VL - 35

SP - 3794

EP - 3795

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 34

ER -